Secure Asset Management LLC increased its stake in Zoetis Inc. (NYSE:ZTS – Free Report) by 39.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,297 shares of the company’s stock after acquiring an additional 654 shares during the period. Secure Asset Management LLC’s holdings in Zoetis were worth $374,000 at the end of the most recent reporting period.
Several other hedge funds have also modified their holdings of the stock. Darwin Wealth Management LLC purchased a new stake in Zoetis during the 3rd quarter worth about $31,000. First Personal Financial Services purchased a new stake in shares of Zoetis during the third quarter worth approximately $33,000. Capital Performance Advisors LLP purchased a new stake in shares of Zoetis during the third quarter worth approximately $33,000. Dunhill Financial LLC raised its holdings in Zoetis by 80.6% in the third quarter. Dunhill Financial LLC now owns 168 shares of the company’s stock valued at $33,000 after acquiring an additional 75 shares in the last quarter. Finally, Quarry LP lifted its stake in Zoetis by 273.2% in the second quarter. Quarry LP now owns 209 shares of the company’s stock worth $36,000 after acquiring an additional 153 shares during the last quarter. 92.80% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of equities research analysts have commented on ZTS shares. Leerink Partners initiated coverage on shares of Zoetis in a research report on Monday, December 2nd. They issued an “outperform” rating and a $215.00 price objective on the stock. UBS Group started coverage on Zoetis in a research note on Monday, December 9th. They issued a “neutral” rating and a $196.00 price target on the stock. Leerink Partnrs raised Zoetis to a “strong-buy” rating in a report on Monday, December 2nd. Stifel Nicolaus dropped their price objective on Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a report on Tuesday, January 7th. Finally, JPMorgan Chase & Co. boosted their target price on Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. One investment analyst has rated the stock with a hold rating, nine have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, Zoetis has an average rating of “Buy” and an average target price of $211.89.
Zoetis Price Performance
ZTS stock opened at $168.63 on Friday. The business has a 50 day simple moving average of $170.23 and a 200-day simple moving average of $179.71. The company has a market capitalization of $76.08 billion, a P/E ratio of 31.70, a PEG ratio of 2.57 and a beta of 0.89. Zoetis Inc. has a twelve month low of $144.80 and a twelve month high of $200.53. The company has a current ratio of 3.69, a quick ratio of 2.27 and a debt-to-equity ratio of 1.26.
Zoetis (NYSE:ZTS – Get Free Report) last posted its quarterly earnings data on Monday, November 4th. The company reported $1.58 EPS for the quarter, beating analysts’ consensus estimates of $1.46 by $0.12. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. The company had revenue of $2.40 billion for the quarter, compared to analyst estimates of $2.29 billion. During the same period in the previous year, the business posted $1.36 earnings per share. Zoetis’s quarterly revenue was up 11.6% on a year-over-year basis. As a group, equities analysts anticipate that Zoetis Inc. will post 5.9 EPS for the current year.
Zoetis Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 4th. Shareholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.19%. This is a boost from Zoetis’s previous quarterly dividend of $0.43. The ex-dividend date of this dividend is Tuesday, January 21st. Zoetis’s dividend payout ratio (DPR) is presently 37.59%.
Zoetis Profile
Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.
Read More
- Five stocks we like better than Zoetis
- What is Put Option Volume?
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- How to Short a Stock in 5 Easy StepsĀ
- 3 Buy-and-Hold Stocks for Long-Term Growth
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Despite Short-Term Risks Freeport McMoran Worth a Look
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS – Free Report).
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.